Previous 10 | Next 10 |
ATLANTA, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces today that it will repor...
ATLANTA, May 24, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, today announces tha...
2023-05-19 08:20:32 ET Foot Locker FL -25% after Q1 earning release . Phio Pharmaceuticals ( PHIO ) -12% . Infobird ( IFBD ) -12% . Alimera Sciences ( ALIM ) -11% . Enveric Biosciences ( ENVB ) -10% . Eledon Pharmaceuticals ( E...
2023-05-19 06:00:00 ET 3 Tips for Shifting Your Mindset When Swing Trading Penny Stocks Navigating the world of penny stocks calls for a distinct blend of market knowledge, discernment, and resilience. Penny stocks , often associated with small-scale enterprises, offer attractive gr...
2023-05-18 18:38:14 ET Gainers: Farfetch Limited ( FTCH ) +18% . Ouster ( OUST ) +9%. Guardforce AI ( GFAI ) +4% . GSI Technology ( GSIT ) +4%. Losers: CaliberCos ( CWD ) -9%. Flowers Foods ( FLO ) -5%. DXC Te...
2023-05-18 10:04:28 ET Gainers: Enveric Biosciences ( ENVB ) +68% . Alimera Sciences ( ALIM ) +35% . Corvus Pharmaceuticals ( CRVS ) +12% . Viracta Therapeutics ( VIRX ) +11% . Bullfrog AI Holdings ( BFRG ) +8% . Losers: N...
2023-05-18 07:49:20 ET Nano-cap pharma Alimera Sciences ( NASDAQ: ALIM ) added ~48% pre-market Thursday after announcing the acquisition of U.S. commercial rights for eye disorder therapy Yutiq from EyePoint Pharmaceuticals ( NASDAQ: EYPT ). The treatment, also known...
Expected to be immediately accretive to revenue and Adjusted EBITDA in 2023 Alimera projects at least $100 million of consolidated net revenue and over $20 million of Adjusted EBITDA* in 2024 Leverages Alimera’s existing U.S. commercial infrastructure In...
ATLANTA, May 17, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces today that it will host i...
2023-05-15 07:54:51 ET Alimera Sciences press release ( NASDAQ: ALIM ): Q1 GAAP EPS of -$0.71 misses by $0.19 . Revenue of $13.55M (+14.0% Y/Y) beats by $1.25M . For further details see: Alimera Sciences GAAP EPS of -$0.71 misses by $0.19, revenue of $13....
News, Short Squeeze, Breakout and More Instantly...
Alimera Sciences Inc. Company Name:
ALIM Stock Symbol:
NASDAQ Market:
Alimera Sciences Inc. Website:
2024-07-07 16:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, NY / ACCESSWIRE / July 3, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Perficient, Inc. (NASDAQ:PRFT)'s sal...
NEW YORK, NY / ACCESSWIRE / June 26, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Alimera Sciences, Inc. (NASDAQ:ALIM)'...